Riboflavin immobilized Fe3O4 magnetic nanoparticles carried with n-butylidenephthalide as targeting-based anticancer agents
n-Butylidenephthalide (BP) is a potential anti-cancer drug, which can be extracted from Angelica sinensis (Danggui). Previous reports have shown the effectiveness of BP in treating cancer diseases. However, BP has no targeting capacity towards specific cancer cells. To improve treatment efficiency a...
Main Authors: | Ching-Yi Wu, Yu-Chie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2018.1548473 |
Similar Items
-
Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood–Brain Barrier and Suppresses Growth of Glioblastoma
by: Lin YL, et al.
Published: (2020-01-01) -
Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas
by: Pei-Yin Chen, et al.
Published: (2022-05-01) -
Antitumor Effects of <i>N</i>-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells
by: Kai-Fu Chang, et al.
Published: (2020-05-01) -
Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells
by: Sheng-Chun Chiu, et al.
Published: (2017-12-01) -
Cinidium officinale and its Bioactive Compound, Butylidenephthalide, Inhibit Laser-Induced Choroidal Neovascularization in a Rat Model
by: Yun Mi Lee, et al.
Published: (2015-11-01)